The application of pH-sensitive polymer-lipids to antigen delivery forcancer immunotherapy

Biomaterials

Volumn 34, Issue 22, 2013, Pages 5711-5721

  Yuba, Eiji ^a   Kono, Yoshikazu ^a   Harada, Atsushi ^a   Yokoyama, Shoichi ^b   Arai, Masaya ^b   Kubo, Kazuhiro ^b   Kono, Kenji ^a  

^a Osaka Prefecture University   (Japan)

^b NOF Corporation   (Japan)

Author keywords

Cancer immunotherapy; Cellular immunity; Cytoplasmic delivery; Dendritic cell; PH sensitive liposome; PH sensitive polymer

Indexed keywords

CANCER IMMUNOTHERAPY; CELLULAR IMMUNITY; CYTOPLASMIC DELIVERY; DENDRITIC CELLS; PH SENSITIVE; PH-SENSITIVE LIPOSOMES;

ANTIGENS; CELLS; LIPIDS; LIPOSOMES; MAMMALS;

POLYMERS;

2 CARBOXYCYCLOHEXANE 1 CARBOXYLPOLY(GLYCIDOL); 3 METHYLGLUTARYLPOLY(GLYCIDOL); ANTIGEN; LIPID; LIPOSOME; OVALBUMIN; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; POLYMER; PYRAN DERIVATIVE; UNCLASSIFIED DRUG;

ACIDITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CELLULAR IMMUNITY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOSOL; DENDRITIC CELL; DRUG RELEASE; EGG YOLK; FEMALE; LIPOSOMAL DELIVERY; MOLECULAR STABILITY; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL; TUMOR REGRESSION;

ANIMALS; ANTIGENS; ARYLSULFONATES; CELL LINE; FEMALE; HYDROGEN-ION CONCENTRATION; IMMUNITY; IMMUNIZATION; IMMUNOTHERAPY; LIPIDS; LIPOSOMES; MICE; MICE, INBRED C57BL; NEOPLASMS; OVALBUMIN; PHOSPHATIDYLETHANOLAMINES; PHYCOERYTHRIN; POLYMERS; RHODAMINES; TEMPERATURE;

MUS;

EID: 84877623554     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.04.007     Document Type: Article

References (44)

1. Cheng J.C., Moore T.B., Sakamoto K.M. RNA interference and human disease. Mol Genet Metab 2003, 80:121-128.
2. Kouraklis G. Gene therapy for cancer. Dig Dis Sci 2000, 45:1045-1052.
3. Hatefi A., Canine B.F. Perspectives in vector development for systemic cancer gene therapy. Gene Ther Mol Biol 2009, 13:15-19.
4. Coussens L.M., Zitvogel L., Palucka A.K. Neutralizing tumor-promoting chronic inflammation: a magic bullet?. Science 2013, 339:286-291.
5. Palucka K., Banchereau J. Cancer immunotherapy via dendritic cells. Nat Rev Cancer 2012, 12:265-277.
6. Itaka K., Kataoka K. Progress and prospects of polyplex nanomicelles for plasmid DNA delivery. Curr Gene Ther 2011, 11:457-465.
7. Nishiyama N., Kataoka K. Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol Ther 2006, 112:630-648.
8. Sasaki Y., Akiyoshi K. Nanogel engineering for new nanobiomaterials: from chaperoning engineering to biomedical applications. Chem Rec 2010, 10:366-376.
9. Buyens K., De Smedt S.C., Braeckmans K., Demeester J., Peeters L., van Grunsven L.A., et al. Liposome based systems for systemic siRNA delivery: stability in blood sets the requirements for optimal carrier design. JControl Release 2012, 158:362-370.
10. Primo M.N., Bak R.O., Mikkelsen J.G. Lentiviral vectors for cutaneous RNA managing. Exp Dermatol 2012, 21:162-170.
11. Zelphati O., Szoka F.C. Liposomes as a carrier for intracellular delivery of antisense oligonucleotides: a real or magic bullet?. JControl Release 1996, 99-119.
12. Kunisawa J., Nakanishi T., Takahashi I., Okudaira A., Tsutsumi Y., Katayama K., et al. Sendai virus fusion protein mediates simultaneous induction of MHC class I/II-dependent mucosal and systemic immune responses via the nasopharyngeal-associated lymphoreticular tissue immune system. JImmunol 2001, 167:1406-1412.
13. Shibata S., Okano S., Yonemitsu Y., Onimaru M., Sata S., Nagata-Takeshita H., et al. Induction of efficient antitumor immunity using dendritic cells activated by recombinant Sendai virus and its modulation by exogenous IFN-β gene. JImmunol 2006, 177:3564-3576.
14. Murthy N., Robichaud J.R., Tirrell D.A., Stayton P.S., Hoffman A.S. The design and synthesis of polymers for eukaryotic membrane disruption. JControl Release 1999, 61:137-143.
15. Fattal E., Couvreur P., Dubernet C. "Smart" delivery of antisense oligonucleotides by anionic pH-sensitive liposomes. Adv Drug Deliv Rev 2004, 56:931-946.
16. Ellens H., Bentz J., Szoka F.C. pH-Induced destabilization of phosphatidylethanolamine-containing liposomes: role of bilayer contact. Biochemistry 1984, 23:1532-1538.
17. Chen T., McIntosh D., He Y., Kim J., Tirrell D.A., Schrerrer P., et al. Alkylated derivatives of poly(ethylacrylic acid) can be inserted into preformed liposomes and trigger pH-dependent intracellular delivery of liposomal contents. Mol Membr Biol 2004, 21:385-393.
18. Kono K., Zenitani K., Takagishi T. Novel pH-sensitive liposomes: liposomes bearing a poly(ethylene glycol) derivative with carboxyl groups. Biochim Biophys Acta 1994, 1193:1-9.
19. Kono K., Igawa T., Takagishi T. Cytoplasmic delivery of calcein mediated by liposomes modified with a pH-sensitive poly(ethylene glycol) derivative. Biochim Biophys Acta 1997, 1325:143-154.
20. Meyer O., Papahadjopoulos D., Leroux J.C. Copolymers of N-isopropylacrylamide can trigger pH sensitivity to stable liposomes. FEBS Lett 1998, 421:61-64.
21. Sakaguchi N., Kojima C., Harada A., Kono K. Preparation of pH-sensitive poly(glycidol) derivatives with varying hydrophobicities: their ability to sensitize stable liposomes to pH. Bioconjug Chem 2008, 19:1040-1048.
22. Yuba E., Harada A., Sakanishi Y., Kono K. Carboxylated hyperbranched poly(glycidol)s for preparation of pH-sensitive liposomes. JControl Release 2011, 149:72-80.
23. Roberts M.J., Bentley M.D., Harris J.M. Chemistry for peptide and protein PEGylation. Adv Drug Deliv Rev 2002, 54:459-476.
24. Kainthan R.K., Janzen J., Levin E., Devine D.V., Brooks D.E. Biocompatibility testing of branched and linear polyglycidol. Biomacromolecules 2006, 7:703-709.
25. Imran ul-haq M., Lai B.F.L., Chapanian R., Kizhakkedathu J.N. Influence of architecture of high molecular weight linear and branched polyglycerols on their biocompatibility and biodistribution. Biomaterials 2012, 33:9135-9147.
26. Ringsdorf H., Venzmer J., Winnik F.M. Interaction of hydrophobically-modified poly-N-isopropylacrylamides with model membranes-or playing a molecular accordion. Angew Chem Int Ed Engl 1991, 30:315-318.
27. Kono K. Thermosensitive polymer-modified liposomes. Adv Drug Deliv Rev 2001, 53:307-319.
28. Kono K., Nakai R., Morimoto K., Takagishi T. Thermosensitive polymer-modified liposomes that release contents around physiological temperature. Biochim Biophys Acta 1999, 1416:239-250.
29. Daleke D.L., Hong K., Papahadjopoulos D. Endocytosis of liposomes bymacrophages: binding, acidification and leakage of liposomes monitored by a new fluorescence assay. Biochim Biophys Acta 1990, 1024:352-366.
30. Shen Z., Reznikoff G., Dranoff G., Rock K.L. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. JImmunol 1997, 158:2723-2730.
31. Moore M.W., Carbone F.R., Bevan M.J. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 1988, 54:777-785.
32. Kaganer V.M., Mohwald H., Dutta P. Structure and phase transitions in Langmuir monolayers. Rev Mod Phys 1999, 71:779-819.
33. Sacre M.M., Tocanne J.F. Importance of glycerol and fatty acid residues on the ionic properties of phosphatidylglycerols at the air-water interface. Chem Phys Lipids 1977, 18:334-354.
34. Sacre M.M., Hoffmann W., Turner M., Tocanne J.F., Chapman D. Differential scanning calorimetric studies of some phosphatidyl glycerol lipid-water systems. Chem Phys Lipids 1979, 69:69-83.
35. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
36. Mellman I., Steinman R.M. Dendritic cells: specialized and regulated antigen processing machines. Cell 2001, 106:255-258.
37. Banchereau J., Palucka A.K. Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 2005, 5:296-306.
38. 5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. JExp Med 1998, 188:1359-1368.
39. Yuba E., Kojima C., Harada A., Tana, Watarai S., Kono K. pH-Sensitive fusogenic polymer-modified liposomes as a carrier of antigenic proteins for activation of cellular immunity. Biomaterials 2010, 31:943-951.
40. Yuba E., Kojima C., Sakaguchi N., Harada A., Koiwai K., Kono K. Gene delivery to dendritic cells mediated by complexes of lipoplexes and pH-sensitive fusogenic polymer-modified liposomes. JControl Release 2008, 130:77-83.
41. Padilla-Parra S., Matos P.M., Kondo N., Marin M., Santos N., Melikyan G.B. Quantitative imaging of endosome acidification and single retrovirus fusion with distinct pool of early endosomes. Proc Natl Acad Sci U S A 2012, 109:17627-17632.
42. Straubinger R.M., Papahadjopoulos D., Hong K. Endocytosis and intracellular fate of liposomes using pyranine as a probe. Biochemistry 1990, 29:4929-4939.
43. Dennis A.M., Rhee W.J., Sotto D., Dublin S.N., Bao G. Quantum dot-fluorescent protein FRET probes for sensing intracellular pH. ACS Nano 2012, 6:2917-2924.
44. Yuba E., Harada A., Sakanishi Y., Watarai S., Kono K. Aliposome-based antigen delivery system using pH-sensitive fusogenic polymers for cancer immunotherapy. Biomaterials 2013, 34:3042-3052.